| Dr Roberto Carlos Montes, PSYD | |
|
80 B Veterans Blvd, Acoma, NM 87034 | |
| (505) 552-5300 | |
| (505) 552-5490 |
| Full Name | Dr Roberto Carlos Montes |
|---|---|
| Gender | Male |
| Speciality | Clinical Psychologist |
| Experience | 20 Years |
| Location | 80 B Veterans Blvd, Acoma, New Mexico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639523855 | NPI | - | NPPES |
| 34858 | Other | TX | LICENSE PSYCHOLOGIST |
| H3451 | Medicaid | NM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 34858 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Senior Psychological Care Sa I Llc | 5193999860 | 11 |
News Archive
Concuity, a healthcare division of Trintech (Nasdaq: TTPA) and a leading provider of Revenue Cycle Management technology and services, announced the new release of ClearContracts(TM) 9.0. Used by the largest and most sophisticated hospital systems in the U.S., ClearContracts(TM) is a web-based suite of software that enables healthcare providers to meet all of their managed care and revenue recovery goals.
Merck today reported initial results from the Phase III study investigating the efficacy and safety of a treatment regimen including ISENTRESS® (raltegravir) Tablets once daily in treatment-naïve adult patients infected with HIV-1. ISENTRESS is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in treatment-naïve and treatment-experienced adults.
In an effort to understand the ongoing evolution of the SARS-CoV-2 genome, researchers constructed a phylogenetic tree of all available SARS-CoV-2 genomes.
Digoxin, a drug widely used to treat heart disease, increases the possibility of death when used by patients with a common heart rhythm problem − atrial fibrillation (AF), according to new study findings by University of Kentucky researchers. The results have been published in the prestigious European Heart Journal, and raises serious concerns about the expansive use of this long-standing heart medication in patients with AF.
› Verified 5 days ago
| Entity Name | Dhhs,phs,naihs, Gallup Indian Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225002322 PECOS PAC ID: 3173436409 Enrollment ID: O20031111000840 |
News Archive
Concuity, a healthcare division of Trintech (Nasdaq: TTPA) and a leading provider of Revenue Cycle Management technology and services, announced the new release of ClearContracts(TM) 9.0. Used by the largest and most sophisticated hospital systems in the U.S., ClearContracts(TM) is a web-based suite of software that enables healthcare providers to meet all of their managed care and revenue recovery goals.
Merck today reported initial results from the Phase III study investigating the efficacy and safety of a treatment regimen including ISENTRESS® (raltegravir) Tablets once daily in treatment-naïve adult patients infected with HIV-1. ISENTRESS is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in treatment-naïve and treatment-experienced adults.
In an effort to understand the ongoing evolution of the SARS-CoV-2 genome, researchers constructed a phylogenetic tree of all available SARS-CoV-2 genomes.
Digoxin, a drug widely used to treat heart disease, increases the possibility of death when used by patients with a common heart rhythm problem − atrial fibrillation (AF), according to new study findings by University of Kentucky researchers. The results have been published in the prestigious European Heart Journal, and raises serious concerns about the expansive use of this long-standing heart medication in patients with AF.
› Verified 5 days ago
| Entity Name | Senior Psychological Care Sa I Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205122355 PECOS PAC ID: 5193999860 Enrollment ID: O20111114000886 |
News Archive
Concuity, a healthcare division of Trintech (Nasdaq: TTPA) and a leading provider of Revenue Cycle Management technology and services, announced the new release of ClearContracts(TM) 9.0. Used by the largest and most sophisticated hospital systems in the U.S., ClearContracts(TM) is a web-based suite of software that enables healthcare providers to meet all of their managed care and revenue recovery goals.
Merck today reported initial results from the Phase III study investigating the efficacy and safety of a treatment regimen including ISENTRESS® (raltegravir) Tablets once daily in treatment-naïve adult patients infected with HIV-1. ISENTRESS is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in treatment-naïve and treatment-experienced adults.
In an effort to understand the ongoing evolution of the SARS-CoV-2 genome, researchers constructed a phylogenetic tree of all available SARS-CoV-2 genomes.
Digoxin, a drug widely used to treat heart disease, increases the possibility of death when used by patients with a common heart rhythm problem − atrial fibrillation (AF), according to new study findings by University of Kentucky researchers. The results have been published in the prestigious European Heart Journal, and raises serious concerns about the expansive use of this long-standing heart medication in patients with AF.
› Verified 5 days ago
| Entity Name | Canoncito Band Of Navajos Health Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578010070 PECOS PAC ID: 8325321235 Enrollment ID: O20170425001197 |
News Archive
Concuity, a healthcare division of Trintech (Nasdaq: TTPA) and a leading provider of Revenue Cycle Management technology and services, announced the new release of ClearContracts(TM) 9.0. Used by the largest and most sophisticated hospital systems in the U.S., ClearContracts(TM) is a web-based suite of software that enables healthcare providers to meet all of their managed care and revenue recovery goals.
Merck today reported initial results from the Phase III study investigating the efficacy and safety of a treatment regimen including ISENTRESS® (raltegravir) Tablets once daily in treatment-naïve adult patients infected with HIV-1. ISENTRESS is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in treatment-naïve and treatment-experienced adults.
In an effort to understand the ongoing evolution of the SARS-CoV-2 genome, researchers constructed a phylogenetic tree of all available SARS-CoV-2 genomes.
Digoxin, a drug widely used to treat heart disease, increases the possibility of death when used by patients with a common heart rhythm problem − atrial fibrillation (AF), according to new study findings by University of Kentucky researchers. The results have been published in the prestigious European Heart Journal, and raises serious concerns about the expansive use of this long-standing heart medication in patients with AF.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Roberto Carlos Montes, PSYD 129 Medicine Horse Dr, To'hajiilee, NM 87026 Ph: (505) 908-2307 | Dr Roberto Carlos Montes, PSYD 80 B Veterans Blvd, Acoma, NM 87034 Ph: (505) 552-5300 |
News Archive
Concuity, a healthcare division of Trintech (Nasdaq: TTPA) and a leading provider of Revenue Cycle Management technology and services, announced the new release of ClearContracts(TM) 9.0. Used by the largest and most sophisticated hospital systems in the U.S., ClearContracts(TM) is a web-based suite of software that enables healthcare providers to meet all of their managed care and revenue recovery goals.
Merck today reported initial results from the Phase III study investigating the efficacy and safety of a treatment regimen including ISENTRESS® (raltegravir) Tablets once daily in treatment-naïve adult patients infected with HIV-1. ISENTRESS is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in treatment-naïve and treatment-experienced adults.
In an effort to understand the ongoing evolution of the SARS-CoV-2 genome, researchers constructed a phylogenetic tree of all available SARS-CoV-2 genomes.
Digoxin, a drug widely used to treat heart disease, increases the possibility of death when used by patients with a common heart rhythm problem − atrial fibrillation (AF), according to new study findings by University of Kentucky researchers. The results have been published in the prestigious European Heart Journal, and raises serious concerns about the expansive use of this long-standing heart medication in patients with AF.
› Verified 5 days ago
Dr. Yvonne Lutter, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 80b Veterans Blvd, Acoma, NM 87034 Phone: 505-552-5300 Fax: 505-552-5828 | |
Dr. Emily King, PSY.D. Psychologist Medicare: Medicare Enrolled Practice Location: 80 B Veterans Blvd, Acoma, NM 87034 Phone: 505-552-5300 Fax: 505-552-5828 |